This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Endoscopic Retrograde Cholangiopancreatography (ECRP) Devices Market

Market Insights on Endoscopic Retrograde Cholangiopancreatography (ECRP) Devices covering sales outlook, demand forecast & up-to-date key trends

Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market by Product Type, Line Capacity, Application & Region - Forecast 2022 – 2032

Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook (2022-2032)

[324 Pages Report] The global endoscopic retrograde cholangiopancreatography (ERCP) devices market is estimated to reach US$ 1.5 Bn in 2022, and anticipated to reach US$ 2.8 Bn by 2032, owing to an increase in cancer cases across the globe. As per FMI, the endoscopic retrograde cholangiopancreatography (ERCP) devices market is likely to exhibit the growth at a CAGR of 6.2% during the forecast period from 2022 to 2032.

Report Attribute

Details

Endoscopic Retrograde Cholangiopancreatography Devices Market Anticipated Forecast Value (2022)

US$ 1.5 Billion

Endoscopic Retrograde Cholangiopancreatography Devices Market Anticipated Forecast Value (2032)

US$ 2.8 Billion

Endoscopic Retrograde Cholangiopancreatography Devices Market Projected Growth Rate (2022-2032)

6.2% CAGR

Endoscopic retrograde cholangiopancreatography (ERCP) device is a mixed fluoroscopic and endoscopic procedure wherein an endoscope is introduced into the second part of the duodenum, therefore enabling other tools to be incorporated into the biliary and pancreatic ducts through the key duodenal papilla.

ERCP devices use an amalgamation of luminal endoscopy and fluoroscopic imaging to diagnose and treat disorders related to pancreaticobiliary. These devices make use of a side-view duodenoscopy and are introduced through the esophagus and stomach into the stomach section of the duodenum. Endoscopic retrograde cholangiopancreatography (ERCP) devices are mainly used for extracting samples of cells and tissues or for treating blocked bile or pancreatic duct.

Substitutes for ERCP devices consist of magnetic resonance cholangiopancreatography devices and computed tomography machines, and therefore there is a strong demand for endoscopic retrograde cholangiopancreatography devices in the coming years.

The market is majorly driven by increasing cancer cases, added investments by governments and healthcare facilities to enhance endoscopy research, rising adoption of minimally invasive procedures and surgeries, and major hospitals investing in improved endoscopy research.

The COVID-19 pandemic has adversely affected all industries across the globe. Surgeons and patients who visited hospitals for varied treatments were at a higher risk of getting infected by the virus. Several gastrointestinal procedures were halted or stopped, and this led to reduced device-based treatments such as ERCP.

Based on research, the pandemic considerably decreased ERCP procedures. Approximately 50 per cent of endoscopy procedures were annulled in several primary hospitals across Germany. In the UK and worldwide, the success rate diminished owing to restrictions on endoscopic services.

All these factors adversely affected the endoscopic retrograde cholangiopancreatography (ERCP) devices market. Furthermore, the endoscopy procedure is believed to be a procedure that generates aerosol; this possessed as a threat and risk of transmission to healthcare professionals.

Customize this Report

Let us know your requirement to get
100% FREE customization

Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices market is driven by increasing prevalence of cancer

The growth of the Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices market is attributed to the rising number of cancer cases and a paradigm shift toward minimally invasive procedures.

Several other factors such as an increase in incidences of chronic biliary and gastrointestinal disorders like colitis, Barrett’s disease, Crohn’s disease, biliary disease, pancreatitis, gastroesophageal reflux disorder (GERD), peptic ulcer disease, liver disease, and inflammatory bowel disease, support the demand for endoscopic retrograde cholangiopancreatography (ERCP) devices and thereby contribute to the higher growth rate of the ERCP devices market.

There is a swift rise in the frequencies of benign tumours of the pancreas and liver along with the rising geriatric population, which contributes to the market growth of endoscopic retrograde cholangiopancreatography (ERCP) devices.

Additionally, there is more awareness pertaining to the devices which are used in ERCP for treating disorders. Currently, there is various ongoing research done towards safer use and enhanced efficiency of these endoscopic retrograde cholangiopancreatography (ECRP) devices. This, coupled with increasing government support for R&D, could fuel the market growth for endoscopic retrograde cholangiopancreatography (ECRP) devices throughout the forecast period

Opportunities for the Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices

Amongst the economies across the world, the swiftest growing ones are Brazil, Russia, India, China, and South Africa (BRICS). As per the World Economic Forum, the developing economies attributed for nearly one-third of the worldwide expenditure in 2021.

Over half of the world’s population resides in China and India, and this makes their countries with the highest patient population. The fastest enhancements in healthcare infrastructure, rising burden of cancer, existence of flexible regulation, and speedy growth in medical tourism in these emerging countries promotes market players in the endoscopy equipment market to bloom their footprint in these countries.

Various manufacturers of endoscopy equipment are presently setting up their facilities in Latin America, Asia Pacific, and the Middle East. For instance, giants like Karl Storz have established their R&D and manufacturing facilities in these countries.

Moreover, in the developed regions, market saturation is observed. Therefore, in regions like Europe and North America, manufacturers are forced to focus more on emerging market in the future years. All these abovementioned are projected to render considerable growth opportunities for the ERCP market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Market Restricting Factors of Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices?

ERCP devices and procedures are expensive, and therefore the high costs pertaining to the treatment from ERCP are one of the key factors hampering the market growth and hence the demand for endoscopic retrograde cholangiopancreatography (ERCP) devices.

Also, the risks and side-effects of the treatment procedure like post-ERCP pancreatitis are anticipated to hinder the growth of the market during the forecast period. Furthermore, for several small-scale end users, these procure are not easily accessible and are not affordable.

What is the Regional Analysis of Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Share?

Region-wise, North America's Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices market is projected to bloom considerably due to a greater number of research related to diagnostic imaging and improved R&D for novel upgraded ECRP devices.

In 2019, North America accounted for a larger market share owing to the well-established healthcare infrastructure in this region and the existence of key players and their product availability. Excess expenditure and enhanced healthcare infrastructure are projected to boost the Europe market for ECRP devices during the forecast period.

Nevertheless, Asia Pacific is said to garner higher CAGR since several governments of the countries from this region are focusing on investing in the development of healthcare infrastructure.

Also, increasing awareness about cholangiopancreatography procedures in Japan, China and India will promote the growth of the market in the Asia Pacific. Additionally, in 2021, China and Japan attributed for nearly 60% market share at the regional level, owing to increased cases of Gastrointestinal cancers in both these countries.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Competition

Some of the most prominent companies in the global endoscopic retrograde cholangiopancreatography (ERCP) devices market are Olympus Corporation, Boston Scientific Corporation, CONMED Corporation, Cook Medical, Inc., Fujifilm Holdings Corporation, Hobbs Medical, Merit Medical Systems and, TeleMed Systems, Inc.

Recently, the manufacturers operating in the endoscopic retrograde cholangiopancreatography (ERCP) devices have been engaged in novel product launches, acquisitions, and partnerships, to gain considerable position in the market. For example, Fujifilm Holdings Corporation in March 2021 acquired the diagnostic imaging-related business of Hitachi Ltd., to make its healthcare business more robust.

Scope Of Report

Report Attribute

Details

Growth rate

CAGR of 6.2% from 2022 to 2032

Base year for estimation

2021

Historical data

2015 - 2020

Forecast period

2022 - 2032

Quantitative units

Revenue in USD million, volume in kilotons, and CAGR from 2022 to 2032

Report coverage

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis

Segments covered

Disease Indication, Product Type, End User, Region

Regional scope

North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand

Country scope

U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa

Key companies profiled

Olympus Corporation, Boston Scientific Corporation, CONMED Corporation, Cook Medical, Inc., Hobbs Medical, Merit Medical Systems and, TeleMed Systems, Inc., Fujifilm Holdings Corporation

Customization scope

Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs.

Frequently Asked Questions

The global endoscopic retrograde cholangiopancreatography (ERCP) devices market is estimated to grow at a CAGR of 6.2% from 2022 to 2032.

North America is the key region accountable for highest revenue generation in this market.

Some of the key players in the market include Olympus Corporation, Boston Scientific Corporation, CONMED Corporation, Cook Medical, Inc., Hobbs Medical, Merit Medical Systems and, Fujifilm Holdings Corporation, TeleMed Systems, Inc.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity 

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Disease Indication

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Disease Indication, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Disease Indication, 2022-2032

        5.3.1. Gastroesophageal Reflux Disease

        5.3.2. GI Cancer

        5.3.3. Barrett's Esophagus

        5.3.4. Bile Duct Diseases

        5.3.5. Peptic Ulcer Disease

        5.3.6. Crohn's Disease

        5.3.7. Intestinal Pseudo-Obstruction and Ogilvie Syndrome

        5.3.8. Other Disease Indications

    5.4. Y-o-Y Growth Trend Analysis By Disease Indication, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Disease Indication, 2022-2032

6. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product Type, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product Type, 2022-2032

        6.3.1. Sphincterotomes

        6.3.2. Lithotripter

        6.3.3. Endoscopes

        6.3.4. Accessories

        6.3.5. Stents

        6.3.6. Cannulas

        6.3.7. Forceps

        6.3.8. Snares

        6.3.9. Catheters

        6.3.10. Guiding Wires

        6.3.11. Balloons

        6.3.12. Others (Baskets etc.)

    6.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032

7. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast 2022-2032, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End User, 2017-2021

    7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End User, 2022-2032

        7.3.1. Hospitals

        7.3.2. Specialty Clinics

        7.3.3. Diagnostic Laboratories

        7.3.4. Others

    7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021

    7.5. Absolute $ Opportunity Analysis By End User, 2022-2032

8. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021

    8.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. East Asia

        8.3.5. South Asia & Pacific

        8.3.6. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Disease Indication

        9.2.3. By Product Type

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Disease Indication

        9.3.3. By Product Type

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Mexico

            10.2.1.2. Brazil

            10.2.1.3. Rest of Latin America

        10.2.2. By Disease Indication

        10.2.3. By Product Type

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Disease Indication

        10.3.3. By Product Type

        10.3.4. By End User

    10.4. Key Takeaways

11. Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. Italy

            11.2.1.3. France

            11.2.1.4. U.K.

            11.2.1.5. Spain

            11.2.1.6. BENELUX

            11.2.1.7. Russia

            11.2.1.8. Rest of Europe

        11.2.2. By Disease Indication

        11.2.3. By Product Type

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Disease Indication

        11.3.3. By Product Type

        11.3.4. By End User

    11.4. Key Takeaways

12. East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

        12.2.2. By Disease Indication

        12.2.3. By Product Type

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Disease Indication

        12.3.3. By Product Type

        12.3.4. By End User

    12.4. Key Takeaways

13. South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. ASEAN

            13.2.1.3. Australia and New Zealand

            13.2.1.4. Rest of South Asia & Pacific

        13.2.2. By Disease Indication

        13.2.3. By Product Type

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Disease Indication

        13.3.3. By Product Type

        13.3.4. By End User

    13.4. Key Takeaways

14. MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    14.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

    14.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. Turkey

            14.2.1.3. South Africa

            14.2.1.4. Rest of MEA

        14.2.2. By Disease Indication

        14.2.3. By Product Type

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Disease Indication

        14.3.3. By Product Type

        14.3.4. By End User

    14.4. Key Takeaways

15. Key Countries Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis

    15.1. U.S.

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Disease Indication

            15.1.2.2. By Product Type

            15.1.2.3. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Disease Indication

            15.2.2.2. By Product Type

            15.2.2.3. By End User

    15.3. Mexico

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Disease Indication

            15.3.2.2. By Product Type

            15.3.2.3. By End User

    15.4. Brazil

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Disease Indication

            15.4.2.2. By Product Type

            15.4.2.3. By End User

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Disease Indication

            15.5.2.2. By Product Type

            15.5.2.3. By End User

    15.6. Italy

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Disease Indication

            15.6.2.2. By Product Type

            15.6.2.3. By End User

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Disease Indication

            15.7.2.2. By Product Type

            15.7.2.3. By End User

    15.8. U.K.

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Disease Indication

            15.8.2.2. By Product Type

            15.8.2.3. By End User

    15.9. Spain

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Disease Indication

            15.9.2.2. By Product Type

            15.9.2.3. By End User

    15.10. BENELUX

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Disease Indication

            15.10.2.2. By Product Type

            15.10.2.3. By End User

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Disease Indication

            15.11.2.2. By Product Type

            15.11.2.3. By End User

    15.12. China

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Disease Indication

            15.12.2.2. By Product Type

            15.12.2.3. By End User

    15.13. Japan

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Disease Indication

            15.13.2.2. By Product Type

            15.13.2.3. By End User

    15.14. South Korea

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Disease Indication

            15.14.2.2. By Product Type

            15.14.2.3. By End User

    15.15. India

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Disease Indication

            15.15.2.2. By Product Type

            15.15.2.3. By End User

    15.16. ASEAN

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Disease Indication

            15.16.2.2. By Product Type

            15.16.2.3. By End User

    15.17. Australia and New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Disease Indication

            15.17.2.2. By Product Type

            15.17.2.3. By End User

    15.18. GCC Countries

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Disease Indication

            15.18.2.2. By Product Type

            15.18.2.3. By End User

    15.19. Turkey

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Disease Indication

            15.19.2.2. By Product Type

            15.19.2.3. By End User

    15.20. South Africa

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2021

            15.20.2.1. By Disease Indication

            15.20.2.2. By Product Type

            15.20.2.3. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Disease Indication

        16.3.3. By Product Type

        16.3.4. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Olympus Corporation

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. Boston Scientific Corporation

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. CONMED Corporation

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. Cook Medical, Inc.

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. Hobbs Medical

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. Merit Medical Systems

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. TeleMed Systems, Inc.

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Region, 2017-2032

Table 3: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032

Table 4: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Disease Indication, 2017-2032

Table 5: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 6: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Product Type, 2017-2032

Table 7: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 8: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by End User, 2017-2032

Table 9: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 10: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Country, 2017-2032

Table 11: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032

Table 12: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Disease Indication, 2017-2032

Table 13: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 14: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Product Type, 2017-2032

Table 15: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 16: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by End User, 2017-2032

Table 17: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 18: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Country, 2017-2032

Table 19: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032

Table 20: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Disease Indication, 2017-2032

Table 21: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 22: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Product Type, 2017-2032

Table 23: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 24: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by End User, 2017-2032

Table 25: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 26: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Country, 2017-2032

Table 27: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032

Table 28: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Disease Indication, 2017-2032

Table 29: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 30: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Product Type, 2017-2032

Table 31: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 32: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by End User, 2017-2032

Table 33: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 34: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Country, 2017-2032

Table 35: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032

Table 36: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Disease Indication, 2017-2032

Table 37: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 38: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Product Type, 2017-2032

Table 39: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 40: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by End User, 2017-2032

Table 41: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 42: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Country, 2017-2032

Table 43: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032

Table 44: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Disease Indication, 2017-2032

Table 45: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 46: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Product Type, 2017-2032

Table 47: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 48: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by End User, 2017-2032

Table 49: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 50: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Country, 2017-2032

Table 51: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032

Table 52: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Disease Indication, 2017-2032

Table 53: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 54: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Product Type, 2017-2032

Table 55: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 56: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by End User, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Disease Indication, 2022-2032

Figure 2: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Product Type, 2022-2032

Figure 3: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by End User, 2022-2032

Figure 4: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Region, 2022-2032

Figure 5: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 6: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Region, 2017-2032

Figure 7: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 8: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 9: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032

Figure 10: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Disease Indication, 2017-2032

Figure 11: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032

Figure 12: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032

Figure 13: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 14: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Product Type, 2017-2032

Figure 15: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 16: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 17: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 18: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by End User, 2017-2032

Figure 19: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 20: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 21: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Disease Indication, 2022-2032

Figure 22: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Product Type, 2022-2032

Figure 23: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by End User, 2022-2032

Figure 24: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Region, 2022-2032

Figure 25: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Disease Indication, 2022-2032

Figure 26: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Product Type, 2022-2032

Figure 27: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by End User, 2022-2032

Figure 28: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Country, 2022-2032

Figure 29: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 30: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Country, 2017-2032

Figure 31: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 32: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 33: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032

Figure 34: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Disease Indication, 2017-2032

Figure 35: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032

Figure 36: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032

Figure 37: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 38: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Product Type, 2017-2032

Figure 39: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 40: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 41: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 42: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by End User, 2017-2032

Figure 43: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 44: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 45: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Disease Indication, 2022-2032

Figure 46: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Product Type, 2022-2032

Figure 47: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by End User, 2022-2032

Figure 48: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Country, 2022-2032

Figure 49: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Disease Indication, 2022-2032

Figure 50: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Product Type, 2022-2032

Figure 51: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by End User, 2022-2032

Figure 52: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Country, 2022-2032

Figure 53: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 54: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Country, 2017-2032

Figure 55: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 56: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 57: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032

Figure 58: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Disease Indication, 2017-2032

Figure 59: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032

Figure 60: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032

Figure 61: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 62: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Product Type, 2017-2032

Figure 63: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 64: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 65: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 66: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by End User, 2017-2032

Figure 67: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 68: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 69: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Disease Indication, 2022-2032

Figure 70: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Product Type, 2022-2032

Figure 71: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by End User, 2022-2032

Figure 72: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Country, 2022-2032

Figure 73: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Disease Indication, 2022-2032

Figure 74: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Product Type, 2022-2032

Figure 75: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by End User, 2022-2032

Figure 76: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Country, 2022-2032

Figure 77: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 78: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Country, 2017-2032

Figure 79: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 80: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 81: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032

Figure 82: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Disease Indication, 2017-2032

Figure 83: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032

Figure 84: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032

Figure 85: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 86: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Product Type, 2017-2032

Figure 87: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 88: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 89: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 90: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by End User, 2017-2032

Figure 91: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 92: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 93: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Disease Indication, 2022-2032

Figure 94: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Product Type, 2022-2032

Figure 95: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by End User, 2022-2032

Figure 96: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Country, 2022-2032

Figure 97: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Disease Indication, 2022-2032

Figure 98: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Product Type, 2022-2032

Figure 99: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by End User, 2022-2032

Figure 100: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Country, 2022-2032

Figure 101: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 102: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Country, 2017-2032

Figure 103: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 104: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 105: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032

Figure 106: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Disease Indication, 2017-2032

Figure 107: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032

Figure 108: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032

Figure 109: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 110: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Product Type, 2017-2032

Figure 111: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 112: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 113: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 114: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by End User, 2017-2032

Figure 115: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 116: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 117: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Disease Indication, 2022-2032

Figure 118: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Product Type, 2022-2032

Figure 119: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by End User, 2022-2032

Figure 120: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Country, 2022-2032

Figure 121: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Disease Indication, 2022-2032

Figure 122: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Product Type, 2022-2032

Figure 123: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by End User, 2022-2032

Figure 124: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Country, 2022-2032

Figure 125: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 126: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Country, 2017-2032

Figure 127: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 128: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 129: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032

Figure 130: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Disease Indication, 2017-2032

Figure 131: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032

Figure 132: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032

Figure 133: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 134: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Product Type, 2017-2032

Figure 135: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 136: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 137: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 138: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by End User, 2017-2032

Figure 139: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 140: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 141: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Disease Indication, 2022-2032

Figure 142: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Product Type, 2022-2032

Figure 143: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by End User, 2022-2032

Figure 144: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Country, 2022-2032

Figure 145: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Disease Indication, 2022-2032

Figure 146: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Product Type, 2022-2032

Figure 147: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by End User, 2022-2032

Figure 148: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Country, 2022-2032

Figure 149: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 150: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Country, 2017-2032

Figure 151: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 152: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 153: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032

Figure 154: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Disease Indication, 2017-2032

Figure 155: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032

Figure 156: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032

Figure 157: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 158: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Product Type, 2017-2032

Figure 159: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 160: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 161: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 162: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by End User, 2017-2032

Figure 163: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 164: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 165: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Disease Indication, 2022-2032

Figure 166: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Product Type, 2022-2032

Figure 167: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by End User, 2022-2032

Figure 168: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Functional Endoscopic Sinus Surgery Systems Market

Published : November 2018

Healthcare

Mobile Endoscopic Workstations Market

Published : September 2017

Healthcare

Endoscopic Vessel Harvesting System Market

Published : June 2016

Healthcare

Endoscopy Visualization Components Market

Published : January 1970

Google translate

Endoscopic Retrograde Cholangiopancreatography (ECRP) Devices Market